查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1250696

全球 Ubiotics 市场：到 2028 年的预测——按产品、形式、牲畜、应用、最终用户和地区分析

Eubiotics Market Forecasts to 2028 - Global Analysis By Product, Form, Livestock, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2022 年全球益生菌市场规模将达到 50.9 亿美元，预计 2028 年将达到 93.7 亿美元，预测期内復合年增长率为 10.7%。

Eubiotics 由饲料厂、预混器或某些分销商製造和销售。Eubiotics 由直接销售给消费者或整合饲料製造商的企业生产。在这两种情况下，农民都会收到 Eubiotics 产品。Eubiotics 使用发酵和化学合成等技术来製造有机酸。

据世界银行称，采用工业化肉类生产的增长速度是传统肉类生产的六倍。据世界卫生组织称，美国每年约有 200 万人遭受抗生素耐药性感染，导致约 23,000 人死亡。

市场动态：

促进者

牲畜疾病增加

有利于这个市场的主要因素之一是全球牲畜疾病的增加。以益生元为基础的饮食餵养的动物不仅可以获得重要的营养素，而且还具有健康和治疗益处，例如慢性病的早期发现和治疗。此外，消费者对饲料质量和安全意识的增强也有助于扩大市场。在动物和家畜中，益生菌经常被用作抗生素生长促进剂 (AGP) 的替代品。相应地，对动物蛋白和肉类的需求不断增长，也推动了对益生菌不断增长的需求。动物作为宠物的驯化和畜牧业的快速现代化，特别是在发达国家，预计将成为进一步的促成因素。

抑製剂

对生态学的无知

一些国家禁止使用抗生素，但它们仍在畜牧业中使用。此外，过度使用抗生素会促进抗菌素耐药性 (AMR) 的发展。具有抗菌素耐药性 (AMR) 的动物对治疗没有反应，这使得疾病更难治疗，并增加了疾病传播、严重疾病和死亡的风险。不幸的是，许多农民不愿意改用益生菌，因为他们不知道抗生素的有害影响。因此，缺乏关于益生菌益处的知识是一个主要的商业风险。

机会

一种称为 eubiotics 的新替代方法

最近的科学发现表明，共生素（益生菌 + 益生元）在家禽饮食中促进健康并提高动物生产力。源自植物多酚的芳香化合物具有抗氧化能力并抑制细菌胞外□和氧化磷酸化，有助于防止感染利用代谢底物和吸收营养。这个动作提高了身体的免疫反应。由于对健康动物饲料添加剂的重要性有了更深入的了解，Eubiotics 在世界范围内得到越来越广泛的采用。

威胁

原材料价格飙升

原材料成本上涨已成为全球饲料生产商面临的主要问题。益生元来自有机材料，如种子、树皮和树叶。益生菌市场受到有关生物废物原料和废水处理的严格法规以及这些原料不断上升的提取成本的限制。随着世界人口的增长和由此产生的食品需求的增加，动物饲料行业面临着确保玉米、小麦和大麦等饲料原料安全的巨大压力。此外，植物提取物和精油等原料新用于医药和化妆品，其成本也在上升。由此，饲料添加剂生产企业承担的运营成本也在不断攀升。这些因素可能会在预期期间限制市场扩张。

COVID-19 的影响

益生菌行业受到 COVID-19 爆发的轻微影响。由于主要市场的流动受到严格限制，企业遭受了财务损失，但对整个行业的影响喜忧参半。然而，此次疫情提高了公众对食用动物使用抗生素危害的认识，这对益生菌业务的增长产生了积极影响。COVID-19 已导致全球工厂、生产和製造设施、餐厅、住宿设施等关闭。结果，出现了劳动力短缺、供应链中断和原材料供应减少的情况。

有机酸部分预计在预测期内将是最大的

据估计，有机酸领域将有有利可图的增长。这些酸在动物营养中用作饲料和谷物防腐剂。通过防止霉菌和细菌感染的发展，帮助提高饲料资源的利用率。可应用于家禽、水产养殖、养猪等项目。有机酸的使用已被证明可有效解决饲料质量和卫生问题。所有这些特征预计将在预测期内推动有机酸部门的增长。

肠道环境部分预计在预测期内復合年增长率最高

由于动物经常有消化问题和预防保健的日益普及，预计肠道环境部分在预测期内将见证最快的复合年增长率。Eubiotics 产品将微生物群集中在动物的胃肠道内，有助于改善消化和免疫系统。可以改善肠道完整性，尤其是通过使用益生菌、有机酸和精油等产品。这些产品可以单独使用或组合使用以获得更好的效果。

市场占有率最高的地区

在预测期内，北美预计将占据最大的市场份额。这是因为益生菌在畜牧业领域的使用越来越多。由于该地区存在多家益生菌製造公司，预计该市场也将增长。对动物製成的产品的需求不断增长，以及政府为保护畜牧业而製定的不断扩大的法规正在推动北美市场的增长，其次是欧洲。由于对益生菌替代品的负面影响的高度认识，该地区的农民也在采用益生菌来餵养牲畜并满足需求。

复合年增长率最高的地区：

预计欧洲在预测期内的复合年增长率最高，这是由于对益生菌益处的普遍认识提高、严格法规的实施以及抗生素的禁令。高质量饲料添加剂的采用以及对动物健康和安全的日益关注正在推动该地区益生菌市场的增长。技术改进、研发支出和主要参与者的存在进一步加强了欧洲市场。

重大发展

2021 年 7 月，活跃于材料、健康和营养领域的荷兰跨国公司 Koninklijke DSM NV 将开发创新的靶向益生菌，将显着改善环境影响和动物健康。宣布已收购生物技术公司 Midori USA, Inc.初创公司。

2021年1月，领先的畜牧业营养与健康解决方案供应商Novus International, Inc.将藉助研发合作和解决方案扩大客户群，开发原始和创意产品，宣布与Massachusetts biotech建立合作伙伴关係创新者 Agrivida。

本报告提供的内容

  • 区域和国家细分市场份额评估
  • 对新进入者的战略建议
  • 涵盖 2020、2021、2022、2025 和 2028 年的市场数据
  • 市场驱动因素（市场趋势、制约因素、机会、威胁、挑战、投资机会/建议等）
  • 基于市场估计的关键业务领域的战略建议
  • 竞争格局和趋势
  • 公司概况，包括详细战略、财务状况和近期发展
  • 供应链趋势反映了最新的技术进步。

提供免费定制

购买此报告的客户将免费获得以下定制之一。

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 个）
    • 主要参与者的 SWOT 分析（最多 3 人）
  • 区域部分
    • 应客户要求提供主要国家的市场预估、预测和CAGR（注：通过可行性检查）
  • 竞争标桿
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

目录

第一章内容提要

第二章前言

  • 概述
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 研究来源
    • 主要研究来源
    • 二手研究资源
    • 假设

第三章市场趋势分析

  • 促进者
  • 抑製剂
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5 全球 Ubiotics 市场，按产品

  • 益生元
    • 低聚果糖 (FOS)
    • 低聚半乳糖 (GOS)
    • 菊粉
    • 甘露寡糖 (MOS)
  • 益生菌
    • 链球菌
    • 乳酸菌
    • 双歧桿菌
  • 有机酸
    • 醋酸
    • 富马酸
    • 甲酸
    • 乳酸
    • 丙酸
  • 香精油
  • 酵素
  • 致战斗力
  • 其他产品

6 全球益生菌市场：按形式分类

  • 液体
  • 坚硬的

7. 全球 Eubiotics 市场，按牲畜分类

  • 家禽
  • 猪
  • 反刍动物
  • 水生动物
  • 其他牲畜

9 全球 Ubiotics 市场，按应用

  • 免疫
  • 肠道健康
  • 屈服
  • 营养
  • 其他用途

10. 全球 Ubiotics 市场，按最终用户分类

  • 家禽饲料
  • 牲畜饲料
  • 猪饲料
  • 水产饲料
  • 其他最终用户

11. 全球 Ubiotics 市场，按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东

第十二章主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章公司简介

  • BEHN MEYER
  • DSM
  • Novus International, Inc.
  • Advanced BioNutrition Corp
  • Lallemand, Inc.
  • DuPont de Nemours, Inc.
  • Associated British Foods plc
  • Novozymes
  • Calpis Co., Ltd.
  • UAS Laboratories
  • BENEO
  • Koninklijke DSM N.V
  • Lesaffre Group
  • Evonik Industries AG
  • Chr. Hansen Holding A/S
  • Cargill, Incorporated
  • BASF SE
  • Biomin
  • ADM
  • Bluestar Adisseo Co.
Product Code: SMRC22573

According to Stratistics MRC, the Global Eubiotics Market is accounted for $5.09 billion in 2022 and is expected to reach $9.37 billion by 2028 growing at a CAGR of 10.7% during the forecast period. Eubiotics are manufactured and distributed by feed mills, pre-mixers, or particular distributors. Eubiotics are produced by businesses that either offers their goods directly to consumers or to integrate feed producers. In any case, the animal farmers receive the Eubiotics products. Eubiotics are produced using techniques like fermentation and chemical synthesis to create organic acids.

According to the World Bank, the adoption of industrialized meat production is growing 6 times faster than that of traditional meat production. According to WHO, about 2 million people in the U.S. suffer from antibiotic resistant infections each year while death toll reaches nearly 23,000.

Market Dynamics:

Driver:

Increasing prevalence of livestock diseases

One of the main elements fostering a favourable view for the market is the rising occurrence of livestock diseases around the world. Animals fed on feed based on eubiotics receive critical nutrients as well as health and therapeutic advantages, such as the early detection and treatment of chronic disorders. Also, rising consumer awareness of feed quality and safety is contributing to market expansion. In animals and livestock, eubiotics are frequently employed as an alternative to antibiotic growth promoters (AGPs). In accordance with this, the rising demand for Eubiotics is also being fuelled by the rising need for animal protein and meat. Additional causes, particularly in industrialised nations, are projected to push the domestication of animals as pets and the quick modernization of the cattle business.

Restraint:

Unawareness about eubiotics

Although being outlawed in some countries, antibiotics are nonetheless utilised in the livestock industry. Moreover, overusing antibiotics can encourage the development of antimicrobial resistance (AMR). Animals that develop antimicrobial resistance (AMR) do not respond to treatment, making illnesses harder to treat and raising the risk of disease transmission, serious illness, and death. Unfortunately, many farmers are reluctant to transition to eubiotics because they are unaware of the harmful effects of antibiotics. Therefore, a major commercial danger is the lack of knowledge about the advantages of eubiotics.

Opportunity:

New alternative approach of eubiotics

Recent scientific discoveries suggest that symbiotic (probiotics + prebiotics) can promote a healthy and increased rate of animal production in poultry diets. Aromatic compounds derived from plant polyphenols that have antioxidant capabilities and suppress bacterial extracellular enzymes and oxidative phosphorylation aid in preventing infections from utilising their metabolic substrates and absorbing nutrients. The body's immunological responses are improved by this function. Eubiotics are being adopted more widely across the globe as a result of growing understanding of the significance of healthy animal feed additives.

Threat:

Rising raw material prices

Increasing raw material costs are a significant issue for feed producers all over the world. Eubiotics come from organic materials like seeds, bark, and leaves. The market for eubiotics is being constrained by increasing extraction costs from these sources as well as strict rules on bio-waste materials and wastewater treatment. The animal feed industry is under a lot of pressure to find raw feeds like corn, wheat, and barley as the world's population rises and the resulting demand for food rises. Also, the cost of raw ingredients like plant extracts and essential oils is rising as a result of their new uses in pharmaceutical and cosmetic products. As a result, the operating expenses incurred by producers of feed additives are also rising. These elements will restrict market expansion during the anticipated term.

Covid-19 Impact

The eubiotics industry has been slightly impacted by the COVID-19 epidemic. Although firms have suffered financial losses as a result of significant mobility restrictions in significant markets, the industry's overall impact is mixed. The pandemic has, however, increased public awareness of the harmful effects of antibiotics in food animals, which has positively impacted the growth of the Eubiotics business. Worldwide closures of factories, production and manufacturing facilities, eateries, lodging facilities, and other businesses were brought on by COVID-19. This led to a lack of labour, a breakdown in the supply chain, and a decrease in the supply of raw materials and other supplies.

The organic acids segment is expected to be the largest during the forecast period

The organic acids segment is estimated to have a lucrative growth. These acids are employed in animal nutrition as forage and grain preservatives. They help to improve the utilisation of feed resources by preventing the formation of mould and bacterial infections. They can be applied to projects including poultry, aquaculture, and pigs. The use of organic acids has shown to be a successful remedy for problems with feed quality and sanitation. Over the course of the projection period, all these characteristics are anticipated to fuel segment growth for organic acids.

The gut health segment is expected to have the highest CAGR during the forecast period

The gut health segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the fact that animals frequently experience problems with their digestive systems as well as the rising popularity of preventative healthcare. Eubiotics products aid in aggregating the microbiota production in the animal's digestive tract, improving digestion and the immune system. Gut integrity can be improved by using products like probiotics, probiotics, organic acids, and essential oils, among others. To get better results, these products can be used separately or in combination.

Region with highest share:

North America is projected to hold the largest market shares during the forecast period owing to eubiotics are being used more and more in the livestock field industry. Also, the existence of multiple eubiotics manufacturing enterprises in this area is anticipated to foster the market's expansion there. Due to the rising demand for products made from animals and the expansion of government regulation to safeguard the animal husbandry industry, Europe is now following North America. Also, farmers in this area are employing eubiotics to raise their livestock and meet demand because they are more aware of the negative effects of alternatives to eubiotics.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rising public knowledge of the advantages of eubiotics, the implementation of strict restrictions, and a ban on the use of antibiotics. The adoption of high-quality feed additives in this region, together with growing concerns about animal health and safety, are driving the expansion of the eubiotics market. The market in Europe has been further bolstered by technical improvements, expenditures in research & development, and the presence of major companies.

Key Players in the market

Some of the key players profiled in the Eubiotics Market include BEHN MEYER, DSM, Novus International, Inc., Advanced BioNutrition Corp, Lallemand, Inc., DuPont de Nemours, Inc., Associated British Foods plc, Novozymes, Calpis Co., Ltd., UAS Laboratories, BENEO, Koninklijke DSM N.V, Lesaffre Group, Evonik Industries AG, Chr. Hansen Holding A/S, Cargill, Incorporated, BASF SE, Biomin, ADM and Bluestar Adisseo Co.

Key Developments:

In July 2021, Koninklijke DSM N.V, a Netherlands-based multinational corporation that is engaged in the fields of materials, health, and nutrition, announced that they have acquired Midori USA, Inc., a biotechnological start-up company that is engaged in developing innovative targeted eubiotics that significantly enhance the environmental impact and health of the animals.

In January 2021, Novus International, Inc., a dominant player that provides nutrition and health solutions in the animal agriculture industry, announced that they have partnered with Agrivida, a Massachusetts-based biotech innovator, in order to expand their customer base as well as implore pristine and creative products and solutions with the help of R&D collaboration.

Products Covered:

  • Prebiotics
  • Probiotics
  • Organic Acids
  • Essential Oil
  • Enzymes
  • Phytogenic
  • Other Products

Forms Covered:

  • Liquid
  • Solid

Livestock's Covered:

  • Poultry
  • Swine
  • Ruminants
  • Aquatic Animals
  • Other Livestock's

Applications Covered:

  • Immunity
  • Gut Health
  • Yield
  • Nutrition
  • Other Applications

End Users Covered:

  • Poultry Feed
  • Cattle Feed
  • Swine Feed
  • Aquatic Feed
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Eubiotics Market, By Product

  • 5.1 Introduction
  • 5.2 Prebiotics
    • 5.2.1 Fructo-oligosaccharides (FOS)
    • 5.2.2 Galacto-Oligosaccharides (GOS)
    • 5.2.3 Inulin
    • 5.2.4 Mannan-Oligosaccharides (MOS)
  • 5.3 Probiotics
    • 5.3.1 Streptococcus
    • 5.3.2 Lactobacilli
    • 5.3.3 Bifidobacterum
  • 5.4 Organic Acids
    • 5.4.1 Acetic Acid
    • 5.4.2 Fumaric Acid
    • 5.4.3 Formiv Acid
    • 5.4.4 Lactic Acid
    • 5.4.5 Propionic Acid
  • 5.5 Essential Oil
  • 5.6 Enzymes
  • 5.7 Phytogenic
  • 5.8 Other Products

6 Global Eubiotics Market, By Form

  • 6.1 Introduction
  • 6.2 Liquid
  • 6.3 Solid

7 Global Eubiotics Market, By Livestock

  • 7.1 Introduction
  • 7.2 Poultry
  • 7.3 Swine
  • 7.4 Ruminants
  • 7.5 Aquatic Animals
  • 7.6 Other Livestocks

9 Global Eubiotics Market, By Application

  • 9.1 Introduction
  • 9.2 Immunity
  • 9.3 Gut Health
  • 9.4 Yield
  • 9.5 Nutrition
  • 9.6 Other Applications

10 Global Eubiotics Market, By End User

  • 10.1 Introduction
  • 10.2 Poultry Feed
  • 10.3 Cattle Feed
  • 10.4 Swine Feed
  • 10.5 Aquatic Feed
  • 10.6 Other End Users

11 Global Eubiotics Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 BEHN MEYER
  • 13.2 DSM
  • 13.3 Novus International, Inc.
  • 13.4 Advanced BioNutrition Corp
  • 13.5 Lallemand, Inc.
  • 13.6 DuPont de Nemours, Inc.
  • 13.7 Associated British Foods plc
  • 13.8 Novozymes
  • 13.9 Calpis Co., Ltd.
  • 13.10 UAS Laboratories
  • 13.11 BENEO
  • 13.12 Koninklijke DSM N.V
  • 13.13 Lesaffre Group
  • 13.14 Evonik Industries AG
  • 13.15 Chr. Hansen Holding A/S
  • 13.16 Cargill, Incorporated
  • 13.17 BASF SE
  • 13.18 Biomin
  • 13.19 ADM
  • 13.20 Bluestar Adisseo Co.

List of Tables

  • Table 1 Global Eubiotics Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Eubiotics Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Eubiotics Market Outlook, By Prebiotics (2020-2028) ($MN)
  • Table 4 Global Eubiotics Market Outlook, By Fructo-oligosaccharides (FOS) (2020-2028) ($MN)
  • Table 5 Global Eubiotics Market Outlook, By Galacto-Oligosaccharides (GOS) (2020-2028) ($MN)
  • Table 6 Global Eubiotics Market Outlook, By Inulin (2020-2028) ($MN)
  • Table 7 Global Eubiotics Market Outlook, By Mannan-Oligosaccharides (MOS) (2020-2028) ($MN)
  • Table 8 Global Eubiotics Market Outlook, By Probiotics (2020-2028) ($MN)
  • Table 9 Global Eubiotics Market Outlook, By Streptococcus (2020-2028) ($MN)
  • Table 10 Global Eubiotics Market Outlook, By Lactobacilli (2020-2028) ($MN)
  • Table 11 Global Eubiotics Market Outlook, By Bifidobacterum (2020-2028) ($MN)
  • Table 12 Global Eubiotics Market Outlook, By Organic Acids (2020-2028) ($MN)
  • Table 13 Global Eubiotics Market Outlook, By Acetic Acid (2020-2028) ($MN)
  • Table 14 Global Eubiotics Market Outlook, By Fumaric Acid (2020-2028) ($MN)
  • Table 15 Global Eubiotics Market Outlook, By Formiv Acid (2020-2028) ($MN)
  • Table 16 Global Eubiotics Market Outlook, By Lactic Acid (2020-2028) ($MN)
  • Table 17 Global Eubiotics Market Outlook, By Propionic Acid (2020-2028) ($MN)
  • Table 18 Global Eubiotics Market Outlook, By Essential Oil (2020-2028) ($MN)
  • Table 19 Global Eubiotics Market Outlook, By Enzymes (2020-2028) ($MN)
  • Table 20 Global Eubiotics Market Outlook, By Phytogenic (2020-2028) ($MN)
  • Table 21 Global Eubiotics Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 22 Global Eubiotics Market Outlook, By Form (2020-2028) ($MN)
  • Table 23 Global Eubiotics Market Outlook, By Liquid (2020-2028) ($MN)
  • Table 24 Global Eubiotics Market Outlook, By Solid (2020-2028) ($MN)
  • Table 25 Global Eubiotics Market Outlook, By Livestock (2020-2028) ($MN)
  • Table 26 Global Eubiotics Market Outlook, By Poultry (2020-2028) ($MN)
  • Table 27 Global Eubiotics Market Outlook, By Swine (2020-2028) ($MN)
  • Table 28 Global Eubiotics Market Outlook, By Ruminants (2020-2028) ($MN)
  • Table 29 Global Eubiotics Market Outlook, By Aquatic Animals (2020-2028) ($MN)
  • Table 30 Global Eubiotics Market Outlook, By Other Livestocks (2020-2028) ($MN)
  • Table 31 Global Eubiotics Market Outlook, By Application (2020-2028) ($MN)
  • Table 32 Global Eubiotics Market Outlook, By Immunity (2020-2028) ($MN)
  • Table 33 Global Eubiotics Market Outlook, By Gut Health (2020-2028) ($MN)
  • Table 34 Global Eubiotics Market Outlook, By Yield (2020-2028) ($MN)
  • Table 35 Global Eubiotics Market Outlook, By Nutrition (2020-2028) ($MN)
  • Table 36 Global Eubiotics Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 37 Global Eubiotics Market Outlook, By End User (2020-2028) ($MN)
  • Table 38 Global Eubiotics Market Outlook, By Poultry Feed (2020-2028) ($MN)
  • Table 39 Global Eubiotics Market Outlook, By Cattle Feed (2020-2028) ($MN)
  • Table 40 Global Eubiotics Market Outlook, By Swine Feed (2020-2028) ($MN)
  • Table 41 Global Eubiotics Market Outlook, By Aquatic Feed (2020-2028) ($MN)
  • Table 42 Global Eubiotics Market Outlook, By Other End Users (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.